Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRDye 800BK for Ureter Identification
NCT03387410Phase 2Completed
- Sponsor
- Oxford University Hospitals
- Start
- Apr 2018
- Primary completion
- Nov 2018
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of nerindocianine in ureter injury, sponsored by Oxford University Hospitals. Started Apr 2018; status: completed.
02
Drugs
nerindocianine
03
Conditions
ureter injury
Beyond the preview
Go deeper on NCT03387410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03387410.